Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Tricuspid Valve Thrombus and Pulmonary Embolus in an Infant with Homozygous Thermolabile Methylenetetrahydrofolate Reductase and Heterozygous Prothrombin G20210A Variant

Abstract

We describe an unusual and interesting case of a full-term infant presenting at 7 days of life with HSV pneumonitis and a tricuspid valve thrombus ultimately requiring extracorporeal membrane oxygenation. The infant subsequently developed a pulmonary embolus. The infant was found to be heterozygous for the prothrombin G20210A mutation and homozygous for the methylenetetrahydrofolate reductase C667T mutation. The patient was treated with low molecular weight heparin for a total of 3 months and has not had a recurrent thrombosis. This case illustrates that a combination of congenital and acquired thrombophilic risk factors can contribute to a significant thrombotic event.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Massicotte P, Adams M, Marzinotto V, Brooker L, Andrew M . Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996;128:313–8.

    Article  CAS  Google Scholar 

  2. Plaut A, Sharnoff G . Acute valvular endocarditis in the newborn. Arch Pathol 1935;20:582–6.

    Google Scholar 

  3. Özkutlu S, Saraclar M, Atalay S, Demircin M, Ruacan S . Two-dimensional echocardiographic diagnosis of tricuspid valve noninfective endocarditis due to protein C deficiency (lesion mimicking tricuspid valve myxoma). Jpn Heart J 1991;32:139–45.

    Article  Google Scholar 

  4. Shrestha NK, Moreno FL, Narciso FV, Torres L, Calleja HB . Two-dimensional echocardiographic diagnosis of left atrial thrombus in rheumatic heart disease. A clinicopathologic study. Circulation 1983;67:341–7.

    Article  CAS  Google Scholar 

  5. Riggs T, Paul MH, DeLeon S, Ilbawi M . Two dimensional echocardiography in evaluation of right atrial masses: five cases in pediatric patients. Am J Cardiol 1981;48:961–6.

    Article  CAS  Google Scholar 

  6. Sussmane JB . Thrombotic lesions of the tricuspid valve in the newborn. Clin Pediatr 1986;25:225–7.

    Article  CAS  Google Scholar 

  7. Hartyánszky IL, Kádár K, Hüttl T, Sápi E, Lozsádi K . Thrombotic lesions of the tricuspid valve in a newborn: surgical management. Pediatr Cardiol 1989;10:109–12.

    Article  Google Scholar 

  8. Özkutlu S, Özbarlas N, Özme S, Saraclar M, Gögüs S, Demircin M . Intracardiac thrombosis diagnosed by echocardiography in childhood: predisposing and etiological factors. Int J Cardiol 1993;40:251–6.

    Article  Google Scholar 

  9. Plaut A . Active endocarditis in the newborn (report of 2 cases). Am J Pathol 1939;15:649–50.

    Google Scholar 

  10. Özkutlu S, Özbarlas N, Saraclar M, Öztunc F . Left ventricular thrombosis due to acquired protein-C deficiency diagnosed by two dimensional echocardiography. Jpn Heart J 1992;33:253–8.

    Article  Google Scholar 

  11. Suskan E, Kemahli S, Atalay S, Ertogan F, Karademir S . Intracardiac thrombosis associated with acquired protein C deficiency. Eur J Pediatr 1994;153:862–3.

    Article  CAS  Google Scholar 

  12. Akar N, Suskan E, Gökce H . Factor V 16916-A mutation and high factor VIII levels in a patient with intracardiac thrombosis. Eur J Pediatr 2000;159:941.

    Article  CAS  Google Scholar 

  13. Vayá A, Forner MJ, Estellés A, et al. Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation. Haematologica 2000;85:425–8.

    PubMed  Google Scholar 

  14. Nowak-Göttl U, Wermes C, Junker R, et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999;93:1595–9.

    PubMed  Google Scholar 

  15. Nowak-Göttl U, Strater R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94:3678–82.

    PubMed  Google Scholar 

  16. Münchow N, Kosch A, Schobess R, Junker R, Auberger K, Nowak-Göttl U . Role of genetic prothrombotic risk factors in childhood caval vein thrombosis. Eur J Pediatr 1999;158:S109–12.

    Article  Google Scholar 

  17. Heller C, Schobess R, Kurnik K, et al. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors — a multicentre case–control study. Br J Haem 2000;111:534–9.

    Article  CAS  Google Scholar 

  18. Grow JL, Filman PJ, Pipe SW . Neonatal sinovenous thrombosis associated with homozygous thermolabile methylenetetrahydrofolate reductase in both mother and infant. J Perinatol 2002;22:175–8.

    Article  Google Scholar 

  19. Hogeveen M, Blom HJ, Van Amerongen M, Boogmans B, Van Beynum IM, Van De Bor M . Hyperhomocysteinemia as risk factor for ischemic and hemorrhagic stroke in newborn infants. J Pediatr 2002;141:429–31.

    Article  Google Scholar 

  20. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM . A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698–703.

    CAS  PubMed  Google Scholar 

  21. Kosch A, Junker R, Wermes C, Nowak-Göttl U . Recurrent pulmonary embolism in a 13-year-old male homozygous for the prothrombin G20210A mutation combined with protein S deficiency and increased lipoprotein (a). Thromb Res 2002;105:49–53.

    Article  CAS  Google Scholar 

  22. Nowak-Göttl U, Junker R, Kreuz W, et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001;97:858–62.

    Article  Google Scholar 

  23. Young G, Krohn KA, Packer RJ . Prothrombin G20210A mutation in a child with spinal cord infarction. J Pediatr 1999;134:777–9.

    Article  CAS  Google Scholar 

  24. Knöfler R, Siegert E, Lauterbach I, et al. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy-impact of central venous lines. Eur J Pediatr 1999;158:S147–50.

    Article  Google Scholar 

  25. Schechter GP, Broudy VC, Williams ME . American society of hematology education program book. In: Andrew ME, Monagle P, deVeber G, Chan AKC, editors. Thromboembolic Disease and Antithrombotic Therapy in Newborns. Washington: American Society of Hematology; 2001. pp. 358–69.

    Google Scholar 

  26. Andrew M, Monagle PT, Brooker L . Thromboembolic Complications During Infancy and Childhood. Hamilton: B.C. Decker, Inc.; 2000. pp 1–429.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thornburg, C., Lattimore, K. & Pipe, S. Tricuspid Valve Thrombus and Pulmonary Embolus in an Infant with Homozygous Thermolabile Methylenetetrahydrofolate Reductase and Heterozygous Prothrombin G20210A Variant. J Perinatol 23, 513–515 (2003). https://doi.org/10.1038/sj.jp.7210951

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7210951

This article is cited by

Search

Quick links